Cargando…
Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route
Frovatriptan, a 5-HT(1B) and 5-HT(1D) receptor agonist, is used for the treatment of acute migraine attack. This molecule is classified into second line therapy because of its slow onset of action (peak response obtained after 4 hours of administration) and low bioavailability (25%). Moreover, its t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897358/ https://www.ncbi.nlm.nih.gov/pubmed/27433492 http://dx.doi.org/10.1155/2014/675868 |